Boston, Massachusetts — According to state and local economic development sources FUJIFILM Diosynth Biotechnologies plans to invest $40,000,000.00 to build out new space in Boston. The company plans to occupy the new space in Boston, on or about November 1, 2021. According to the company website As your global CDMO partner we offer complete solutions in pharmaceutical manufacturing  from pre-clinical investigations and process development to commercial cGMP production. For over 25 years, FUJIFILM Diosynth Biotechnology’s mission has been advancing tomorrow’s medicine. As a CDMO, we work in partnership with the most innovative biopharma and biotech companies across the world who are reimagining healthcare’s potential. We help to accelerate their progress, expand their capabilities, streamline their processes, and strengthen their innovation. So when our customers’ potential cures, vaccines, biologics, and accomplishments make strides  or even become new realities for patients we know our work, our manufacturing expertise, and our partnership helped make it happen.

To learn more about FUJIFILM Diosynth Biotechnologies, visit http://fujifilmdiosynth.com/

Company Contact:
Martin Meeson, President and Chief Executive Officer
https://www.linkedin.com/in/martinemeeson/
979-431-3500

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved